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Abstract
Background: Cystic fibrosis (CF) is an autosomal recessive disease that is predominantly seen in
the Caucasian population and involves multiple organs. Traditionally it has been thought that the
kidney is the only organ which does not seem to be generally affected by the disease although the
cystic fibrosis transmembrane conductance regulator (CFTR) gene is expressed in the kidney.
Case presentation: We report the case of an 11 year old boy with cystic fibrosis and nephrotic
syndrome and review the literature that describes nephrotic syndrome and renal involvement in
cystic fibrosis.
Conclusion: With continued advances in the management of cystic fibrosis and improvement in
life expectancy, several unrecognized co-morbidities are expected to emerge. It is important to
screen patients for possible co-morbidities. Urine analysis may be helpful in this group of patients
and any proteinuria should raise the suspicion of cystic fibrosis-related renal disease.
Background
Cystic fibrosis (CF) is a multisystem disease characterized
by chronic respiratory infections and exocrine pancreatic
insufficiency. Recent advancement in therapy has lead to
improvement in survival. Currently, the median age for a
patient with CF is the early 30's [1]. CF is no longer only
a pediatric disease and long term complications are being
more frequently reported in adults.
Patients with CF usually present with symptoms involving
the respiratory and gastrointestinal systems. However,
other systems can be involved in CF including the renal
system. Traditionally the only abnormalities associated
with the renal tract are nephrolithiasis [2,3] and mechan-
ical urological problems associated with coughing [4]. In
this case report, we describe a patient with cystic fibrosis
and nephrotic syndrome. We also review the literature
about renal involvement in CF.
Case presentation
An 11 year old male with CF (homozygous for ∆F508),
mild lung disease and pancreatic insufficiency presented
with facial swelling that progressed to generalized ana-
sarca over four days. There was a history of preceding
upper respiratory symptoms. He denied any change in his
urine color or bowel habit and there was no history of
headache, visual disturbance, jaundice, chest pain or pal-
pitation. The patient remained on his regular medications
which included albuterol, multivitamins and pancreatic
enzymes.
He was admitted with similar symptoms 6 months prior
to this admission. At that time he had hypoalbuminemia
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without proteinuria on a random urine sample. An exten-
sive workup was negative including liver function tests,
viral hepatitis panel, Alpha 1 antitrypsin (stool, blood),
abdominal ultrasound and upper GI endoscopy. He was
treated with albumin infusion and furosemide and no
corticosteroids were needed. However, the etiology for the
hypoalbuminemia was uncertain.
On this admission, he had mildly elevated blood pressure
at 131/73. His weight was 46.7 kg with 8 kg of recent
weight gain. He had periorbital and facial edema and
moderate pitting edema of both lower extremities and
around the sacral area. Otherwise physical examination
was normal.
Laboratory evaluations showed hypoalbuminemia (1.6
mg/dl) with normal kidney function (BUN of 11 mg/dl,
creatinine of 0.4 mg/dl and normal urine microscopic
evaluation without evidence of RBC casts). 24 hour urine
collection revealed nephrotic range proteinuria (3 gm/24
hour). Other laboratory evaluations were normal includ-
ing ASO, C3, C4 and ANA. He underwent percutaneous
renal biopsy which revealed minimal change disease. The
interstitium showed scattered mixed mononuclear
inflammation with rare eosinophils and neutrophils with-
out any evidence of fibrosis. There was no immune
deposit and no significant glomerulosclerosis. The patient
was treated successfully with oral corticosteroids 2 mg/kg/
day and achieved remission after about six weeks of ther-
apy.
Discussion
There is a general perception that the kidney is spared in
patients with CF. However in recent years there have been
increasing reports of renal disease in patients with CF. Sev-
eral anatomical and pathological reports describe renal
abnormalities in association with CF although there is
still a gap in clinical reporting. Glomerular alterations
including glomerulosclerosis [5], deposits of immune
complexes [6], IgA nephropathy [7] and mesangial prolif-
erations, nephrocalcinosis and microscopic hematuria
[8], tubular injury [5,9], diabetic nephropathy [10], fibril-
lary glomerulonephritis [11] and amyloidosis [12,13]
have all been described in patients with CF. There are to
our knowledge, only two cases that of nephrotic syn-
drome related to minimal change disease [14,15] which
have been reported in the medical literature.
Although nephrotic syndrome is rarely encountered with
CF, mild proteinuria is not infrequently found on urine
analysis [5,12]. Castile et al. reported that five out of 23
patients reviewed in an autopsy series had had unex-
plained proteinuria (range, trace to +2) recorded on rou-
tine urine analysis and the majority of these patients were
noted to have renal pathology at autopsy.
Conclusion
Nephrotic syndrome in this patient with cystic fibrosis
could either be coincidental or a complication of CF. With
continued advances in the management of CF and
improvement in life expectancy, several unrecognized co-
morbidities are expected to emerge and it is important
that patients be screened for possible co-morbidities.
Patients with CF are exposed to potentially nephrotoxic
factors, including chronic and acute bacterial infections,
with circulating immune complexes, and antibiotics espe-
cially aminoglycosides. We know that cystic fibrosis-
related diabetes can produce the same microvascular com-
plications including nephropathy recognized in the non-
cystic fibrosis patient population [16-18]. Urine analysis
may be helpful in this group of patients as a screening
tool.
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